Qiu, Jingwen
Wu, Jing
Chen, Wenwen
Ruan, Yu
Mao, Jingning
Li, Shue
Tang, Xuan
Zhao, Lei
Li, Shengbing
Li, Ke
Liu, Dongfang
Duan, Yaqian http://orcid.org/0000-0001-5228-8606
Funding for this research was provided by:
National Natural Science Foundation of China (No. 81900758)
Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission (cstc2021jcyj-msxmX0250)
Article History
Received: 28 August 2023
Accepted: 29 January 2024
First Online: 9 February 2024
Declarations
:
: Ethics approval for all animal procedures was obtained from the Animal Research Committee at Chongqing Medical University ([approval title: The Role of Peptidoglycan in Diabetes-Induced Dysfunctions of Bone Marrow-Derived Circulating Angiogenic Cells], [approval no. (2021)212], and [Date: December 31, 2021]) and conducted in accordance with established standard protocols for animal care. The experiments involving humans were approved by the Ethics Committee of the Second Affiliated Hospital of Chongqing Medical University ([approval title: The Role of Peptidoglycan in Gut-Retina Axis-Mediated Microvascular Injury in Diabetic Retinopathy], [approval no. (2020)47], and [Date: March 25, 2020]). Sample collection was conducted in strict accordance with the tenets of the Declaration of Helsinki and the ARVO statement on human subjects. All animal studies presented in this manuscript were reported in compliance with the ARRIVE guidelines (ExternalRef removed).
: Not applicable.
: The authors declare that they have no competing interests.